This regulatory report is being submitted as part of a retrospective review and remediation per (b)(4) due to an fda audit observation.Product event summary: the ventricular assist device (vad) (b)(4) was not returned for evaluation.The reported low flow and suction events were confirmed via review of the controller log files which intermittent suction events logged within the analyzed period and six (6) low flow alarms were logged since (b)(6) 2021.Information provided by the site revealed that, in addition to the suction and low flow event, the ventricular assist device (vad) patient was dazed, nauseous and had ventricular tachycardia (vt) episodes.The patient was admitted to the intensive care unit (icu).The vad lavare cycle was deactivated and the patient's symptoms were managed with medication.Based on the available information, the device may have caused or contributed to the reported event.Based on the risk documentation, possible causes of the low flow and suction events may be attributed to multiple factors including but not limited to thrombus at the inflow cannula/outflow graft, constriction at the outflow graft, poor vad filling, and/or inappropriate pump rotational speed.Per the instructions for use, cardiac arrhythmia and neurological dysfunction are known potential complications associated with the implantation of a vad.Based on review of past adverse events for this patient, it was noted that the patient had a history of neurological dysfunction.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulant and antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to this event.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.If information is provided in the future, a supplemental report will be issued.
|